FDA — authorised 23 January 2004
- Application: NDA021539
- Marketing authorisation holder: CUMBERLAND PHARMS
- Status: supplemented
FDA authorised Acetadote on 23 January 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 23 January 2004; FDA has authorised it.
CUMBERLAND PHARMS holds the US marketing authorisation.